Riken Vitamin Co., Ltd. (TYO:4526)
2,405.00
-35.00 (-1.43%)
Apr 2, 2025, 2:41 PM JST
Riken Vitamin Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 95,278 | 91,484 | 88,750 | 79,231 | 77,722 | 82,974 | Upgrade
|
Revenue Growth (YoY) | 5.27% | 3.08% | 12.01% | 1.94% | -6.33% | -6.80% | Upgrade
|
Cost of Revenue | 63,747 | 61,598 | 61,506 | 53,666 | 55,711 | 56,595 | Upgrade
|
Gross Profit | 31,531 | 29,886 | 27,244 | 25,565 | 22,011 | 26,379 | Upgrade
|
Selling, General & Admin | 22,274 | 16,941 | 16,638 | 16,007 | 17,268 | 17,559 | Upgrade
|
Research & Development | - | 3,315 | 3,220 | 2,992 | 3,094 | 3,089 | Upgrade
|
Operating Expenses | 22,274 | 20,514 | 20,117 | 19,723 | 20,643 | 21,071 | Upgrade
|
Operating Income | 9,257 | 9,372 | 7,127 | 5,842 | 1,368 | 5,308 | Upgrade
|
Interest Expense | -120 | -112 | -132 | -178 | -665 | -727 | Upgrade
|
Interest & Investment Income | 873 | 671 | 536 | 448 | 416 | 438 | Upgrade
|
Currency Exchange Gain (Loss) | -40 | 267 | 42 | 82 | 513 | -332 | Upgrade
|
Other Non Operating Income (Expenses) | 164 | 96 | 150 | 102 | 252 | 54 | Upgrade
|
EBT Excluding Unusual Items | 10,134 | 10,294 | 7,723 | 6,296 | 1,884 | 4,741 | Upgrade
|
Gain (Loss) on Sale of Investments | 2,685 | 2,090 | 184 | 14,127 | 303 | 120 | Upgrade
|
Gain (Loss) on Sale of Assets | 36 | 3 | - | - | -4 | 1 | Upgrade
|
Asset Writedown | -391 | -558 | -57 | -174 | -359 | 189 | Upgrade
|
Other Unusual Items | -769 | 78 | 7 | 64 | -1,831 | -12,031 | Upgrade
|
Pretax Income | 11,519 | 11,907 | 7,857 | 20,313 | -7 | -6,980 | Upgrade
|
Income Tax Expense | 3,007 | 3,149 | 1,440 | -1,285 | 1,603 | 1,904 | Upgrade
|
Earnings From Continuing Operations | 8,512 | 8,758 | 6,417 | 21,598 | -1,610 | -8,884 | Upgrade
|
Minority Interest in Earnings | -3 | -3 | -3 | -16 | -8 | -49 | Upgrade
|
Net Income | 8,509 | 8,755 | 6,414 | 21,582 | -1,618 | -8,933 | Upgrade
|
Net Income to Common | 8,509 | 8,755 | 6,414 | 21,582 | -1,618 | -8,933 | Upgrade
|
Net Income Growth | 11.92% | 36.50% | -70.28% | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 31 | 33 | 33 | 33 | 33 | 33 | Upgrade
|
Shares Outstanding (Diluted) | 31 | 33 | 33 | 33 | 33 | 33 | Upgrade
|
Shares Change (YoY) | -6.24% | -0.58% | 0.02% | 0.02% | 0.02% | 0.01% | Upgrade
|
EPS (Basic) | 276.53 | 268.42 | 195.51 | 657.99 | -49.34 | -272.46 | Upgrade
|
EPS (Diluted) | 276.53 | 268.42 | 195.51 | 657.99 | -49.34 | -272.46 | Upgrade
|
EPS Growth | 19.36% | 37.29% | -70.29% | - | - | - | Upgrade
|
Free Cash Flow | - | 7,915 | 5,723 | 3,573 | 3,928 | 575 | Upgrade
|
Free Cash Flow Per Share | - | 242.66 | 174.45 | 108.93 | 119.78 | 17.54 | Upgrade
|
Dividend Per Share | 91.000 | 81.000 | 59.000 | 46.000 | 42.000 | 42.000 | Upgrade
|
Dividend Growth | 36.84% | 37.29% | 28.26% | 9.52% | - | 10.53% | Upgrade
|
Gross Margin | 33.09% | 32.67% | 30.70% | 32.27% | 28.32% | 31.79% | Upgrade
|
Operating Margin | 9.72% | 10.24% | 8.03% | 7.37% | 1.76% | 6.40% | Upgrade
|
Profit Margin | 8.93% | 9.57% | 7.23% | 27.24% | -2.08% | -10.77% | Upgrade
|
Free Cash Flow Margin | - | 8.65% | 6.45% | 4.51% | 5.05% | 0.69% | Upgrade
|
EBITDA | - | 12,702 | 10,845 | 9,578 | 5,323 | 9,380 | Upgrade
|
EBITDA Margin | - | 13.88% | 12.22% | 12.09% | 6.85% | 11.30% | Upgrade
|
D&A For EBITDA | 3,039 | 3,330 | 3,718 | 3,736 | 3,955 | 4,072 | Upgrade
|
EBIT | 9,257 | 9,372 | 7,127 | 5,842 | 1,368 | 5,308 | Upgrade
|
EBIT Margin | 9.72% | 10.24% | 8.03% | 7.37% | 1.76% | 6.40% | Upgrade
|
Effective Tax Rate | 26.11% | 26.45% | 18.33% | - | - | - | Upgrade
|
Advertising Expenses | - | 964 | 1,204 | 1,460 | 2,762 | 3,167 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.